跳至主要内容
临床试验/NCT02062164
NCT02062164进行中(未招募)不适用

Effectiveness and Safety of Weight Loss Surgery in Adolescents With Extreme Obesity Within a Structured Pre- and Post-surgery Treatment Program, Subproject 3

Prof. Dr. Martin Wabitsch5 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2013年11月最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
66
试验地点
5
主要终点
BMI change from baseline

研究概览

简要总结

The use of bariatric surgery in adolescents is controversial. On one side, bariatric surgery is the only effective treatment to achieve sustained weight loss in adults with extreme obesity. Comorbidities are reversed and mortality is reduced. In adolescents, bariatric surgery is equally effective; however, due to the paucity of long-term data, the long-term effects and risks are unknown. Thus, due to surgical risk and ethical implications, bariatric surgery is considered experimental in Germany. Nevertheless, case volumes are increasing.

The aim of this study is to evaluate the benefits and risks of adolescent bariatric surgery in the context of a structured preparation and follow-up program. The study is a subproject of the study "Medical and psychosocial implications of adolescent extreme obesity - acceptance and effects of structured care" (DRKS00004172). At 5 German university centers (Ulm, Datteln, Berlin, Essen, Leipzig), youth who undergo bariatric surgery and are participants in the overall project will be enrolled in a structured preparation and follow-up program. The program is designed to improve adherence and compliance and will result in comprehensive follow-up data. In addition to the data gathered in the overall project, subjects participating in subproject 3 will undergo assessments pertinent to bariatric surgery, as proposed in the American Teen-LABS study (http://www.cincinnatichildrens.org/ research/divisions/t/teen-labs/default/). Comparison will be made with BMI matched adolescents who participate in the overall project but do not undergo bariatric surgery.

In November 2014 recruitment for the overall project was completed. However, patients interested in bariatric surgery will still be recruited until September 2016. There assessment will be the same as for patients recruited earlier. However, in an amendment in December 2014, the frequency of assessment via questionnaire was reduced from biannually to annually. In addition, a travel reimbursement of 30€ for each study visit was implemented.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
14 Years 至 24 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • BMI ≥ 35 kg/m2 with severe comorbidity or BMI ≥ 40 kg/m2 with relevant comorbidity
  • completed longitudinal growth
  • stable social surroundings
  • exhaustion of conservative treatment
  • participation in the project "Adolescents with extreme Obesity"
  • adequate compliance and adherence

排除标准

  • treatable causative condition
  • unstable medical, psychosocial or psychiatric comorbidity
  • alcohol or drug abuse
  • pregnancy
  • contraindication for bariatric surgery

结局指标

主要结局

BMI change from baseline

时间窗: 1 year postoperative

次要结局

  • changes in somatic comorbidity(every 12 months for 9 years)
  • changes in psychosocial comorbidity(every 12 months for 9 years)
  • changes in psychiatric comorbidity(every 12 months for 9 years)
  • vitamin deficiencies(every 6 months for 9 years)
  • adherence with postoperative recommendations on supplements, doctors visits and nutrition(every 12 months for 9 years)
  • hunger, food tolerance, gastrointestinal symptoms, dumping(every 12 months for 9 years)
  • BMI(every 6 months for 9 years)
  • schooling, vocation, psychosocial situation, functional impairments(every 12 months for 9 years)
  • eating behavior(every 12 months for 9 years)
  • changes in quality of life: SF36(every 12 months for 9 years)
  • peri- und postoperative complications(every 12 months for 9 years)
  • exercise(every 12 months for 9 years)
  • changes in quality of life: IWQOL(every 12 months for 9 years)

研究者

发起方
Prof. Dr. Martin Wabitsch
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Prof. Dr. Martin Wabitsch

Division Chief Pediatric Endocrinology and Diabetology

University of Ulm

研究点 (5)

Loading locations...

相似试验